Drug Trial Radar · NCT00242047
Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
Last checked: Nov 19, 2026Latest source record: Oct 19, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
12,000
Actual
Start
Mar 2001
Primary completion
Not stated
Study completion Aug 2006
Sponsor
- Lead sponsor
- University of Cape TownAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Aeras; Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan.
- First posted
- Oct 19, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 0 years, up to 24 hours
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
An open label, randomized, controlled, equivalency trial to compare the efficacy of the percutaneous route of administration with the intradermal route of administration of Japanese (Tokyo) 172 BCG, in the prevention of tuberculosis during the first two years of life.
Conditions
- Tuberculosis
Interventions
Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).Biological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevention of tuberculosis with bacteriological or histological confirmation, or meeting strict clinical criteria,in the first 2 years of life.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town.
Cape Town, Western Cape, South Africa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.